Collegium to Participate in Upcoming Investor Conferences

Globe Newswire 30-Apr-2019 4:01 PM

STOUGHTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in May:

• The SunTrust Robinson Humphrey 5^th Annual Life Sciences Summit on Tuesday, May 7^th in New York City. Management will participate in investor meetings.
   
• The RBC Capital Markets Global Healthcare Conference on Wednesday, May 22^nd in New York City. Management will present at 2:05 p.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the company's website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com